Business · 06/03/2024
FDA Denies Hearing Request for Vanda Pharmaceuticals' Proposal to Refuse HETLIOZ Approval
The FDA has denied a request for a hearing regarding Vanda Pharmaceuticals' proposal to refuse approval of a supplemental new drug application for HETLIOZ (tasimelteon) to treat jet lag disorder.